放射線科におけるAI市場規模、シェア、動向、2030年までの世界予測

放射線科におけるAI市場は、2025年の7億6,000万米ドルから2030年には22億7,000万米ドルに達し、年平均成長率（CAGR）24.5%で成長すると予測されています。この成長は、がんの早期発見、病変のセグメンテーション、予測的な治療計画といったAIを活用した診断ツールの導入拡大によって牽引されており、診断精度の向上と放射線科医の作業負荷軽減に寄与しています。腫瘍学、神経画像診断、心血管画像診断におけるこれらのソリューションの適用拡大は、リアルタイムの洞察、個別診断、ワークフローの最適化を可能にするインテリジェントAIプラットフォームへの需要を大幅に押し上げ、ヘルスケアテクノロジー分野において価値の高いビジネスチャンスを生み出しています。

調査範囲：

本レポートは、放射線科におけるAI市場を分析しています。提供内容、機能、モダリティ、適応症、エンドユーザー、地域に基づき、様々な市場セグメントの市場規模と将来の成長可能性を推定することを目的としています。また、主要プレーヤーの競合分析に加え、企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても提供しています。

レポートを購入する理由

本レポートは、既存企業、新規参入企業、中小企業が市場の動向を把握し、市場シェアの拡大を図るのに役立ちます。本レポートを購入した企業は、以下の戦略のいずれか、または組み合わせて活用することで、市場における地位を強化できます。

本レポートでは、以下の点について洞察を提供します。

主要な推進要因の分析：推進要因（医療画像撮影量の増加、放射線科医の作業負荷軽減のためのAIソリューションへの需要の高まり、規制の明確化、承認取得と政府支援の迅速化、AIを活用した放射線画像処理への需要の高まり、AIに特化したスタートアップ企業への資金提供の増加、AI、テクノロジー、アナリティクスソリューションプロバイダーとの連携の増加）、制約要因（導入コストの高さとROIの不確実性、地域間での規制の断片化、希少疾患におけるデータ品質とラベルの不足）、機会（プラットフォーム、マルチモーダルデータ、OEM統合（PACS/EHR/マーケットプレイス）への需要の高まり、新興ヘルスケア市場における未開拓の成長ポテンシャル、予防医療と集団健康管理の拡大、AI統合型ポータブルデバイスまたはハンドヘルドデバイスの拡大）、課題（従来の放射線システムとの統合課題、医師の信頼と説明可能性への要求の低さ、データのプライバシーとセキュリティに関する懸念）が、放射線AI市場の成長に影響を与えています。

• 製品開発／イノベーション：放射線科におけるAI市場における今後の技術、研究開発活動、新製品発売に関する詳細な洞察
• 市場開発：製品、機能、モダリティ、適応症、エンドユーザー、地域別に、収益性の高い新興市場に関する包括的な情報。
• 市場多様化：放射線科におけるAI市場における製品ポートフォリオ、成長地域、最近の開発状況、投資に関する包括的な情報。
• 競合評価：Siemens Healthineers AG（ドイツ）、Microsoft（米国）、Koninklijke Philips N.V.（オランダ）、GE HealthCare（米国）、富士フイルムホールディングス株式会社（日本）、キヤノンメディカルシステムズ株式会社（日本）、Merative（米国）、DeepHealth（RadNet, Inc.）（米国）、Shanghai United Imaging Healthcare Co., LTD（中国）、Hologic, Inc.（米国）、Enlitic, Inc.（米国）など、放射線AI市場の主要プレーヤーの市場シェア、成長戦略、製品提供、および能力の詳細な評価。

 Report Description

The radiology AI market is projected to reach USD 2.27 billion by 2030 from USD 0.76 billion in 2025, at a CAGR of 24.5%. The growth is fueled by the increasing adoption of AI-driven diagnostic tools for early cancer detection, lesion segmentation, and predictive treatment planning, which enhance diagnostic accuracy and reduce radiologist workload. The expanding application of these solutions in oncology, neuroimaging, and cardiovascular imaging is significantly boosting demand for intelligent AI platforms capable of delivering real-time insights, personalized diagnostics, and workflow optimization, creating a high-value opportunity in the healthcare technology landscape.

The workflow optimization segment is expected to witness significant market share during the forecast period.

Based on the function, the radiology AI market is segmented into screening & triage, diagnostic imaging & interpretation (image acquisition, reconstruction & enhancement, image processing, analysis & detection, clinical decision support, others), treatment planning & intervention support (dose planning & optimization, surgical planning & guidance, image-based segmentation & anatomical modeling, others), monitoring & follow-up, reporting & documentation, workflow optimization, research & clinical development, and others. Workflow optimization is projected to record the fastest CAGR in the radiology AI market, driven by its strong economic and operational impact across imaging departments. With global radiologist shortages and rising imaging volumes, health systems are prioritizing AI that enhances productivity through intelligent worklist orchestration and automated case routing, as well as real-time modality utilization and turnaround-time reduction. These solutions streamline communication between technologists and radiologists, reduce the need for repeat scans, facilitate protocol standardization, and help eliminate manual administrative tasks. As hospitals increasingly shift toward value-based care, workflow AI directly supports cost containment, faster patient throughput, and an improved patient experience, making it a key investment area over the forecast period.

The software/SaaS segment is expected to have the largest share in 2025 in the radiology AI market.

By offering, the software/SaaS solutions segment is expected to hold the largest market share in 2025, primarily because they are easier to deploy, update, and scale across multiple imaging modalities. These platforms seamlessly integrate with existing Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and Electronic Health Record (EHR) systems, enabling radiologists to access AI insights directly within their routine workflows without requiring major infrastructure changes. Cloud-based architectures enhance accessibility, support continuous model improvement, and lower upfront capital expenditure.

Additionally, software vendors leverage subscription and usage-based pricing, making adoption budget-friendly while driving strong recurring revenue. Growing regulatory approvals for diagnostic AI tools, along with strong use cases in oncology, neurology, and cardiology, further accelerate the dominance of this technology in the market.

The North America region accounted for a substantial share of the radiology AI market in 2025.

The North American region accounted for a substantial share of the radiology AI market in 2025, driven by significant investments in healthcare infrastructure, the adoption of advanced technology, and high demand for imaging services. The US, in particular, has seen widespread integration of AI into radiology workflows, supported by federal incentives for digital health adoption and regulatory approvals for AI-powered diagnostic tools. In addition, the growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has increased the demand for advanced imaging solutions, fueling the adoption of AI algorithms for image analysis, triage, and workflow optimization. For instance, in April 2025, according to the NIHCM Foundation, chronic diseases continue to pose a major burden on the US healthcare system, accounting for approximately 90% of the USD 4.5 trillion spent on healthcare in 2022, affecting around 60% of people in the US with multiple chronic conditions, thus driving high costs and complex care needs.

Robust investment from both private and public sectors, along with a high concentration of AI startups and established technology companies, further reinforced North American market leadership. Companies such as Aidoc (US), Enlitic, Inc. (US), and GE HealthCare (US) are actively developing AI-enabled platforms for CT, MRI, X-ray, and PET imaging, enhancing diagnostic accuracy and operational efficiency.

However, challenges such as data privacy concerns under HIPAA and clinician hesitancy to fully adopt AI tools remain. Despite these hurdles, the region continues to lead the global radiology AI market due to a combination of advanced healthcare infrastructure, favorable reimbursement policies, high R&D investment, and early adoption of innovative AI technologies.

These factors collectively reinforce North America’s leadership in the radiology AI market.

The breakdown of primary participants is as mentioned below:

• By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation – C Level: 40%, Director Level: 30%, and Others: 30%
• By Region – North America: 40%, Europe: 30%, Asia Pacific: 25%, Latin America: 3%, Middle East & Africa: 2%

Key Players in the Radiology AI Market

The key players functioning in the radiology AI market include Siemens Healthineers AG (Germany), Microsoft (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), Fujifilm Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Merative (US), DeepHealth (RadNet, Inc.) (US), Shanghai United Imaging Healthcare Co., LTD (China),  Hologic, Inc. (US), and Enlitic, Inc. (US).

Research Coverage:

The report analyses the radiology AI market. It aims to estimate the market size and future growth potential of various market segments based on offering, function, modality, indication, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will help established firms and new entrants/smaller firms gauge the market’s pulse, which, in turn, will help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.

This report provides insights into:

Analysis of key drivers: Drivers (increasing medical imaging volumes, rising demand for AI solutions to alleviate radiologist workload, increase in regulatory clarity, accelerated approvals and government support, growing demand for AI-driven radiological image processing, growing funding for AI-focused startups, and rising collaborations with AI, tech, and analytics solution providers, Restraints (high implementation costs and ROI uncertainty, regulatory fragmentation across regions, and data quality and label scarcity for rarer indications), Opportunities (Growing demand for platform, multi-modal data, and OEM integration [PACS/EHR/marketplaces], untapped growth potential in emerging healthcare markets, expansion of preventive care and population health management, and expansion of portable or handheld devices with AI integration), Challenges (integration challenges with legacy radiology systems, limited clinician trust and explainability demands, and concerns over data privacy and security) influencing the growth of the radiology AI market.

• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product launches in the radiology AI market
• Market Development: Comprehensive information on the lucrative emerging markets, by offering, function, modality, indication, end user, and region.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the radiology AI market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the radiology AI market such as Siemens Healthineers AG (Germany), Microsoft (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), Fujifilm Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Merative (US), DeepHealth (RadNet, Inc.) (US), Shanghai United Imaging Healthcare Co., LTD (China),  Hologic, Inc. (US), and Enlitic, Inc. (US).

Table of Contents

1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 STUDY SCOPE 28
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 28
1.3.2 INCLUSIONS & EXCLUSIONS 29
1.3.3 YEARS CONSIDERED 30
1.4 CURRENCY 30
1.5 STAKEHOLDERS 31
2 EXECUTIVE SUMMARY 32
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 32
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS & STRATEGIC DEVELOPMENTS 33
2.3 DISRUPTIVE TRENDS SHAPING MARKET 34
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 35
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 36
3 PREMIUM INSIGHTS 37
3.1 RADIOLOGY AI MARKET OVERVIEW 37
3.2 NORTH AMERICA: RADIOLOGY AI MARKET, BY OFFERING & COUNTRY 38
3.3 RADIOLOGY AI MARKET: GEOGRAPHIC SNAPSHOT 38
4 MARKET OVERVIEW 39
4.1 INTRODUCTION 39
4.2 MARKET DYNAMICS 39
4.2.1 DRIVERS 41
4.2.1.1 Increasing medical imaging volumes 41
4.2.1.2 Rising demand for AI solutions to alleviate radiologist workload 42
4.2.1.3 Increased regulatory clarity, accelerated approvals, and government support 42
4.2.1.4 Growing demand for AI-driven radiological image processing 44
4.2.1.5 Growing funding for AI-focused startups 45
4.2.1.6 Rising collaborations with AI, tech, and analytics solution providers 45
4.2.2 RESTRAINTS 46
4.2.2.1 High implementation costs and ROI uncertainty 46
4.2.2.2 Regulatory fragmentation across regions 47
4.2.2.3 Data quality and label scarcity for rarer indications 48

4.2.3 OPPORTUNITIES 48
4.2.3.1 Growing demand for platform, multi-modal data, and OEM integration (PACS/EHR/marketplaces) 48
4.2.3.2 Untapped growth potential in emerging healthcare markets 49
4.2.3.3 Expansion of preventive care and population health management 50
4.2.3.4 Expansion of portable/handheld devices with AI integration 51
4.2.4 CHALLENGES 51
4.2.4.1 Integration challenges with legacy radiology systems 51
4.2.4.2 Limited clinician trust and explainability demands 52
4.2.4.3 Concerns over data privacy and security 53
4.3 UNMET NEEDS & WHITE SPACES 56
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 57
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 57
5 INDUSTRY TRENDS 59
5.1 PORTER’S FIVE FORCES ANALYSIS 59
5.1.1 BARGAINING POWER OF SUPPLIERS 60
5.1.2 BARGAINING POWER OF BUYERS 60
5.1.3 THREAT OF SUBSTITUTES 60
5.1.4 THREAT OF NEW ENTRANTS 60
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.2 MACROECONOMIC INDICATORS 61
5.2.1 INTRODUCTION 61
5.2.2 GDP TRENDS & FORECAST 61
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 61
5.3 SUPPLY CHAIN ANALYSIS 61
5.4 ECOSYSTEM ANALYSIS 63
5.5 PRICING ANALYSIS 65
5.5.1 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY OFFERING (2024) 66
5.5.2 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY REGION (2024) 66
5.6 KEY CONFERENCES & EVENTS, 2026–2027 67
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68
5.8 INVESTMENT & FUNDING SCENARIO 69
5.9 CASE STUDY ANALYSIS 69
5.10 IMPACT OF 2025 US TARIFFS ON RADIOLOGY AI MARKET 70
5.10.1 INTRODUCTION 70
5.10.2 KEY TARIFF RATES 71
5.10.3 PRICE IMPACT ANALYSIS 72
5.10.4 IMPACT ON COUNTRY/REGION 72
5.10.4.1 US 72
5.10.4.2 Europe 72
5.10.4.3 Asia Pacific 73
5.10.5 IMPACT ON END-USE INDUSTRIES 73
5.10.5.1 Hospitals & healthcare systems 73
5.10.5.2 Diagnostic imaging centers & independent radiology practices 73
5.10.5.3 Academic, research, and life science institutions 74
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 75
6.1 KEY EMERGING TECHNOLOGIES 75
6.1.1 GENERATIVE AI FOR IMAGE RECONSTRUCTION 75
6.1.2 MULTIMODAL AI INTEGRATION 75
6.1.3 FEDERATED LEARNING FRAMEWORKS 76
6.2 COMPLEMENTARY TECHNOLOGIES 76
6.2.1 CLOUD-BASED IMAGING PLATFORMS 76
6.2.2 BLOCKCHAIN FOR DATA INTEGRITY & TRACEABILITY 77
6.2.3 ADVANCED VISUALIZATION & AR/VR TOOLS 77
6.3 TECHNOLOGY/PRODUCT ROADMAP 78
6.4 PATENT ANALYSIS 78
6.4.1 PATENT PUBLICATION TRENDS FOR RADIOLOGY AI MARKET 79
6.4.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 79
6.5 FUTURE APPLICATIONS 82
6.5.1 AI-DRIVEN PRECISION RADIOLOGY & PERSONALIZED TREATMENT PLANNING 82
6.5.2 AUTONOMOUS IMAGING & WORKFLOW ORCHESTRATION 82
6.5.3 PREDICTIVE & PREVENTIVE DIAGNOSTIC PLATFORMS 83
7 REGULATORY LANDSCAPE 84
7.1 REGIONAL REGULATIONS & COMPLIANCE 84
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
7.1.2 REGULATORY FRAMEWORK 89
7.1.2.1 North America 89
7.1.2.2 Europe 90
7.1.2.3 Asia Pacific 90
7.1.2.4 Latin America 92
7.1.2.5 Middle East & Africa 92
7.1.3 INDUSTRY STANDARDS 92
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 94
8.1 DECISION-MAKING PROCESS 94
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 94
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
8.2.2 BUYING CRITERIA 95
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 96
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 97
8.4.1 UNMET NEEDS 97
8.4.2 END-USER EXPECTATIONS 98
8.5 MARKET PROFITABILITY 99
9 RADIOLOGY AI MARKET, BY OFFERING 100
9.1 INTRODUCTION 101
9.2 ON-DEVICE SOFTWARE 101
9.2.1 RISING DEMAND FOR REAL-TIME, SECURE, AND LOW-LATENCY DIAGNOSTIC INTELLIGENCE TO ACCELERATE ADOPTION 101
9.3 SOFTWARE/SAAS 102
9.3.1 GROWING DEMAND FOR SCALABLE, COST-EFFICIENT, CLOUD-BASED RADIOLOGY AI TO SUPPORT MARKET GROWTH 102
10 RADIOLOGY AI MARKET, BY FUNCTION 104
10.1 INTRODUCTION 105
10.2 SCREENING & TRIAGE 106
10.2.1 RISING NEED FOR RAPID IDENTIFICATION AND PRIORITIZATION OF CRITICAL FINDINGS TO DRIVE ADOPTION OF SCREENING & TRIAGE AI 106
10.3 DIAGNOSTIC IMAGING & INTERPRETATION 106
10.3.1 GROWING DEMAND FOR HIGHER DIAGNOSTIC ACCURACY AND WORKLOAD REDUCTION TO ACCELERATE ADOPTION 106
10.4 TREATMENT PLANNING & INTERVENTION SUPPORT 107
10.4.1 RISING DEMAND FOR PRECISE, PERSONALIZED TREATMENT PLANNING TO SUPPORT MARKET GROWTH 107
10.5 MONITORING & FOLLOW-UP 108
10.5.1 RISING NEED FOR QUANTITATIVE, LONG-TERM DISEASE MONITORING TO BOOST MARKET GROWTH 108
10.6 REPORTING & DOCUMENTATION 109
10.6.1 GROWING NEED FOR STANDARDIZED, AUTOMATED RADIOLOGY REPORTING TO CONTRIBUTE TO GROWTH 109
10.7 WORKFLOW OPTIMIZATION 110
10.7.1 RISING NEED FOR EFFICIENT, AUTOMATED RADIOLOGY WORKFLOWS TO FUEL GROWTH 110
10.8 RESEARCH & CLINICAL DEVELOPMENT 111
10.8.1 GROWING DEMAND FOR AI-ACCELERATED IMAGING RESEARCH TO PROPEL MARKET 111
10.9 OTHER FUNCTIONS 112
11 RADIOLOGY AI MARKET, BY MODALITY 113
11.1 INTRODUCTION 114
11.2 CT 115
11.2.1 GROWING NEED FOR FASTER, MORE ACCURATE CT DIAGNOSIS TO DRIVE MARKET GROWTH 115

11.3 MRI 116
11.3.1 ONGOING TECHNOLOGICAL ADVANCEMENTS IN MRI TECHNOLOGY TO SUPPORT GROWTH 116
11.4 X-RAY 116
11.4.1 GROWING NEED TO MANAGE RISING IMAGING VOLUMES TO DRIVE DEMAND FOR AI-ENHANCED X-RAY SYSTEMS 116
11.5 ULTRASOUND 117
11.5.1 ADVANTAGES SUCH AS MINIMALLY INVASIVE NATURE, LOW COST, AND ABSENCE OF IONIZING RADIATION TO BOOST ADOPTION 117
11.6 MAMMOGRAPHY 118
11.6.1 RISING BREAST CANCER BURDEN TO DRIVE AI ADOPTION IN MAMMOGRAPHY 118
11.7 OTHER MODALITIES 119
12 RADIOLOGY AI MARKET, BY INDICATION 120
12.1 INTRODUCTION 121
12.2 ONCOLOGY 121
12.2.1 RISING GLOBAL CANCER BURDEN TO ACCELERATE NEED FOR AI-DRIVEN DIAGNOSTICS 121
12.3 CARDIOLOGY 122
12.3.1 GROWING CARDIOVASCULAR DISEASE PREVALENCE TO BOOST ADOPTION OF CARDIAC IMAGING AI 122
12.4 NEUROLOGY 123
12.4.1 INCREASING STROKE AND NEURODEGENERATIVE CASES TO DRIVE RAPID AI INTEGRATION 123
12.5 PULMONOLOGY/RESPIRATORY DISEASES 124
12.5.1 EXPANDING LUNG DISEASE INCIDENCE TO FUEL DEMAND FOR AI-BASED DETECTION 124
12.6 ORTHOPEDICS 125
12.6.1 RISING TRAUMA AND OSTEOARTHRITIS CASES TO INCREASE NEED FOR MSK AI 125
12.7 WOMEN’S HEALTH 126
12.7.1 GROWING BREAST CANCER SCREENING VOLUMES TO ACCELERATE AI-ENABLED IMAGING ADOPTION 126
12.8 OTHER INDICATIONS 127
13 RADIOLOGY AI MARKET, BY END USER 128
13.1 INTRODUCTION 129
13.2 HOSPITALS 129
13.2.1 INCREASING DEPLOYMENT OF ADVANCED RADIOLOGY AI-ENABLED IMAGING SYSTEMS IN HOSPITALS TO DRIVE MARKET GROWTH 129
13.3 DIAGNOSTIC IMAGING CENTERS 130
13.3.1 RISING VOLUME OF IMAGING PROCEDURES TO STRENGTHEN NEED FOR AI-SUPPORTED IMAGE INTERPRETATION 130
13.4 OTHER END USERS 131
14 RADIOLOGY AI MARKET, BY REGION 133
14.1 INTRODUCTION 134
14.2 NORTH AMERICA 134
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 136
14.2.2 US 139
14.2.2.1 US to dominate global radiology AI market 139
14.2.3 CANADA 142
14.2.3.1 Growing integration of AI in radiology supported by strong research & regulatory frameworks to drive market 142
14.3 EUROPE 145
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 146
14.3.2 GERMANY 148
14.3.2.1 Growing need to advance diagnostic precision through AI-driven imaging to boost market 148
14.3.3 FRANCE 151
14.3.3.1 Need to address regulatory, ethical, and integration challenges in France’s radiology AI market to boost growth 151
14.3.4 UK 154
14.3.4.1 Accelerating AI integration in diagnostic imaging across NHS to spur market growth 154
14.3.5 ITALY 157
14.3.5.1 Regulatory complexity and infrastructure gaps to constrain radiology AI expansion 157
14.3.6 SPAIN 160
14.3.6.1 Advancing digital imaging and AI integration across Spain’s healthcare system to support growth 160
14.3.7 REST OF EUROPE 163
14.4 ASIA PACIFIC 165
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 167
14.4.2 JAPAN 169
14.4.2.1 Strong digital health infrastructure and government-led innovation programs to support growth 169
14.4.3 CHINA 172
14.4.3.1 Rapid adoption and scale-up of AI-enabled radiology in China to drive growth 172
14.4.4 INDIA 176
14.4.4.1 Rising imaging volumes and need for scalable diagnostic solutions to fuel growth 176
14.4.5 SOUTH KOREA 179
14.4.5.1 Integration and validation challenges in South Korea’s radiology AI market to slow growth 179
14.4.6 AUSTRALIA 182
14.4.6.1 Scaling clinical AI from pilot programs to nationwide deployment to boost market 182
14.4.7 REST OF ASIA PACIFIC 184
14.5 LATIN AMERICA 187
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 188
14.5.2 BRAZIL 191
14.5.2.1 Expanding clinical integration and local innovation in radiology AI to fuel market 191
14.5.3 MEXICO 193
14.5.3.1 Integration and regulatory barriers to hinder AI adoption in radiology 193
14.5.4 REST OF LATIN AMERICA 196
14.6 MIDDLE EAST & AFRICA 199
14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 199
14.6.2 GCC COUNTRIES 202
14.6.2.1 Saudi Arabia 205
14.6.2.1.1 Advancing diagnostic intelligence through healthcare digitalization and AI integration to fuel growth 205
14.6.2.2 UAE 209
14.6.2.2.1 Accelerating smart healthcare transformation through AI-enabled radiology to spur growth 209
14.6.2.3 Rest of GCC Countries 212
14.6.3 SOUTH AFRICA 214
14.6.3.1 Growing integration of AI to strengthen diagnostic imaging and clinical efficiency 214
14.6.4 REST OF MIDDLE EAST & AFRICA 217
15 COMPETITIVE LANDSCAPE 221
15.1 OVERVIEW 221
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 221
15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOLOGY AI MARKET 221
15.3 REVENUE ANALYSIS, 2020–2024 224
15.4 MARKET SHARE ANALYSIS, 2024 225
15.5 BRAND/SOFTWARE COMPARISON 227
15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 228
15.6.1 STARS 228
15.6.2 EMERGING LEADERS 228
15.6.3 PERVASIVE PLAYERS 228
15.6.4 PARTICIPANTS 228
15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 230
15.6.5.1 Company footprint 230
15.6.5.2 Region footprint 231
15.6.5.3 Offering footprint 231
15.6.5.4 Function footprint 232
15.6.5.5 Modality footprint 233
15.6.5.6 End-user footprint 234

15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 235
15.7.1 PROGRESSIVE COMPANIES 235
15.7.2 RESPONSIVE COMPANIES 235
15.7.3 DYNAMIC COMPANIES 235
15.7.4 STARTING BLOCKS 235
15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 237
15.7.5.1 Detailed list of key startups/SMEs 237
15.7.5.2 Competitive benchmarking of startups/SMEs 238
15.8 COMPANY VALUATION & FINANCIAL METRICS 240
15.8.1 FINANCIAL METRICS 240
15.8.2 COMPANY VALUATION 241
15.9 COMPETITIVE SCENARIO 241
15.9.1 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS 241
15.9.2 DEALS 242
15.9.3 OTHER DEVELOPMENTS 243
15.10 KEY PLAYERS 244
15.10.1 SIEMENS HEALTHINEERS AG 244
15.10.1.1 Business overview 244
15.10.1.2 Solutions offered 245
15.10.1.3 Recent developments 247
15.10.1.3.1 Product launches 247
15.10.1.3.2 Deals 247
15.10.1.3.3 Other developments 249
15.10.1.4 MnM view 250
15.10.1.4.1 Right to win 250
15.10.1.4.2 Strategic choices 250
15.10.1.4.3 Weaknesses & competitive threats 250
15.10.2 MICROSOFT 251
15.10.2.1 Business overview 251
15.10.2.2 Solutions offered 252
15.10.2.3 Recent developments 253
15.10.2.3.1 Product launches 253
15.10.2.3.2 Deals 254
15.10.2.3.3 Other developments 255
15.10.2.4 MnM view 255
15.10.2.4.1 Right to win 255
15.10.2.4.2 Strategic choices 256
15.10.2.4.3 Weaknesses & competitive threats 256
15.10.3 KONINKLIJKE PHILIPS N.V. 257
15.10.3.1 Business overview 257
15.10.3.2 Solutions offered 259
15.10.3.3 Recent developments 261
15.10.3.3.1 Product launches & approvals 261
15.10.3.3.2 Deals 262
15.10.3.3.3 Other developments 263
15.10.3.4 MnM view 264
15.10.3.4.1 Right to win 264
15.10.3.4.2 Strategic choices 264
15.10.3.4.3 Weaknesses & competitive threats 264
15.10.4 GE HEALTHCARE 265
15.10.4.1 Business overview 265
15.10.4.2 Solutions offered 266
15.10.4.3 Recent developments 267
15.10.4.3.1 Product launches & approvals 267
15.10.4.3.2 Deals 268
15.10.4.3.3 Expansions 270
15.10.4.3.4 Other developments 270
15.10.4.4 MnM view 271
15.10.4.4.1 Right to win 271
15.10.4.4.2 Strategic choices 271
15.10.4.4.3 Weaknesses & competitive threats 271
15.10.5 FUJIFILM HOLDINGS CORPORATION 272
15.10.5.1 Business overview 272
15.10.5.2 Solutions offered 273
15.10.5.3 Recent developments 276
15.10.5.3.1 Product launches & approvals 276
15.10.5.3.2 Deals 276
15.10.5.3.3 Other developments 277
15.10.5.4 MnM view 277
15.10.5.4.1 Right to win 277
15.10.5.4.2 Strategic choices 278
15.10.5.4.3 Weaknesses & competitive threats 278
15.10.6 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.) 279
15.10.6.1 Business overview 279
15.10.6.2 Solutions offered 280
15.10.6.3 Recent developments 281
15.10.6.3.1 Product launches & approvals 281
15.10.6.3.2 Deals 282
15.10.6.3.3 Other developments 282
15.10.7 MERATIVE 283
15.10.7.1 Business overview 283
15.10.7.2 Solutions offered 284
15.10.7.3 Recent developments 285
15.10.7.3.1 Deals 285
15.10.7.3.2 Expansions 286
15.10.7.3.3 Other developments 287
15.10.8 RADNET, INC. (DEEPHEALTH) 288
15.10.8.1 Business overview 288
15.10.8.2 Solutions offered 289
15.10.8.3 Recent developments 291
15.10.8.3.1 Product launches & approvals 291
15.10.8.3.2 Deals 292
15.10.9 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. 293
15.10.9.1 Business overview 293
15.10.9.2 Solutions offered 294
15.10.9.3 Recent developments 295
15.10.9.3.1 Product launches & approvals 295
15.10.9.3.2 Deals 296
15.10.9.3.3 Other developments 296
15.10.10 HOLOGIC, INC. 298
15.10.10.1 Business overview 298
15.10.10.2 Solutions offered 299
15.10.10.3 Recent developments 300
15.10.10.3.1 Product launches & approvals 300
15.10.10.3.2 Deals 301
15.10.10.3.3 Other developments 301
15.10.11 ENLITIC, INC. 303
15.10.11.1 Business overview 303
15.10.11.2 Solutions offered 304
15.10.11.3 Recent developments 305
15.10.11.3.1 Product launches & approvals 305
15.10.11.3.2 Deals 305
15.10.11.3.3 Other developments 306
15.11 OTHER PLAYERS 307
15.11.1 AIDOC 307
15.11.2 VIZ.AI, INC. 308
15.11.3 NANOX 309
15.11.4 QURE.AI 310
15.11.5 ESAOTE S.P.A. 311
15.11.6 BUTTERFLY NETWORK INC. 312
15.11.7 HEARTFLOW INC. 313
15.11.8 SUBTLE MEDICAL, INC. 314
15.11.9 HARISSON.AI 315
15.11.10 ECHONOUS INC. 316
15.11.11 QUIBIM 317
15.11.12 IMAGEN 318
15.11.13 EXO IMAGING, INC. 319
15.11.14 RAD AI 320
16 RESEARCH METHODOLOGY 321
16.1 RESEARCH DATA 321
16.1.1 SECONDARY DATA 322
16.1.1.1 Key data from secondary sources 322
16.1.2 PRIMARY DATA 323
16.1.2.1 Key data from primary sources 324
16.1.2.2 Breakdown of primary sources 325
16.2 RESEARCH APPROACH 326
16.3 MARKET SIZE ESTIMATION 327
16.4 MARKET BREAKDOWN & DATA TRIANGULATION 334
16.5 RESEARCH ASSUMPTIONS 335
16.5.1 MARKET SIZING ASSUMPTIONS 335
16.5.2 OVERALL STUDY ASSUMPTIONS 335
16.6 RISK ASSESSMENT 336
16.7 RESEARCH LIMITATIONS 336
16.7.1 METHODOLOGY-RELATED LIMITATIONS 336
16.7.2 SCOPE-RELATED LIMITATIONS 336
17 APPENDIX 337
17.1 DISCUSSION GUIDE 337
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 342
17.3 CUSTOMIZATION OPTIONS 344
17.4 RELATED REPORTS 345
17.5 AUTHOR DETAILS 346

LIST OF TABLES

TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 30
TABLE 2 RADIOLOGY AI MARKET: IMPACT ANALYSIS 40
TABLE 3 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011–2024 55
TABLE 4 RADIOLOGY AI MARKET: PORTER’S FIVE FORCES ANALYSIS 60
TABLE 5 RADIOLOGY AI MARKET: ROLE IN ECOSYSTEM 64
TABLE 6 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY OFFERING (2024) 66
TABLE 7 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY REGION (2024) 67
TABLE 8 RADIOLOGY AI MARKET: KEY CONFERENCES & EVENTS, 2026–2027 67
TABLE 9 CASE STUDY 1: PRINCESS ALEXANDRA HOSPITAL NHS TRUST: ENHANCING DIAGNOSTIC CONFIDENCE WITH INTEGRATED AI 69
TABLE 10 CASE STUDY 2: EMBRACING AI FOR EFFICIENT CHEST X-RAY REPORTING AND QUALITY ASSURANCE 70
TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 71
TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR
RADIOLOGY AI MARKET 80
TABLE 13 RADIOLOGY AI MARKET: LIST OF PATENTS/PATENT APPLICATIONS 81
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 85
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 86
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 86
TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 88
TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 19 REGULATORY SCENARIO OF NORTH AMERICA 89
TABLE 20 REGULATORY SCENARIO OF EUROPE 90
TABLE 21 REGULATORY SCENARIO OF ASIA PACIFIC 90
TABLE 22 REGULATORY SCENARIO OF LATIN AMERICA 92
TABLE 23 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 92
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
TOP THREE END USERS (%) 95
TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS 96
TABLE 26 UNMET NEEDS IN RADIOLOGY AI MARKET 97
TABLE 27 END-USER EXPECTATIONS IN RADIOLOGY AI MARKET 98
TABLE 28 RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 101
TABLE 29 RADIOLOGY AI MARKET FOR ON-DEVICE SOFTWARE, BY REGION,
2023–2030 (USD MILLION) 102
TABLE 30 RADIOLOGY AI MARKET FOR SOFTWARE/SAAS, BY REGION,
2023–2030 (USD MILLION) 103
TABLE 31 RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 105
TABLE 32 RADIOLOGY AI MARKET FOR SCREENING & TRIAGE, BY REGION,
2023–2030 (USD MILLION) 106
TABLE 33 RADIOLOGY AI MARKET FOR DIAGNOSTIC IMAGING & INTERPRETATION,
BY REGION, 2023–2030 (USD MILLION) 107
TABLE 34 RADIOLOGY AI MARKET FOR TREATMENT PLANNING & INTERVENTION SUPPORT, BY REGION, 2023–2030 (USD MILLION) 108
TABLE 35 RADIOLOGY AI MARKET FOR MONITORING & FOLLOW-UP, BY REGION,
2023–2030 (USD MILLION) 109
TABLE 36 RADIOLOGY AI MARKET FOR REPORTING & DOCUMENTATION, BY REGION,
2023–2030 (USD MILLION) 110
TABLE 37 RADIOLOGY AI MARKET FOR WORKFLOW OPTIMIZATION, BY REGION,
2023–2030 (USD MILLION) 111
TABLE 38 RADIOLOGY AI MARKET FOR RESEARCH & CLINICAL DEVELOPMENT,
BY REGION, 2023–2030 (USD MILLION) 112
TABLE 39 RADIOLOGY AI MARKET FOR OTHER FUNCTIONS, BY REGION,
2023–2030 (USD MILLION) 112
TABLE 40 RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 114
TABLE 41 RADIOLOGY AI MARKET FOR CT, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 42 RADIOLOGY AI MARKET FOR MRI, BY REGION, 2023–2030 (USD MILLION) 116
TABLE 43 RADIOLOGY AI MARKET FOR X-RAY, BY REGION, 2023–2030 (USD MILLION) 117
TABLE 44 RADIOLOGY AI MARKET FOR ULTRASOUND, BY REGION,
2023–2030 (USD MILLION) 118
TABLE 45 RADIOLOGY AI MARKET FOR MAMMOGRAPHY, BY REGION,
2023–2030 (USD MILLION) 119
TABLE 46 RADIOLOGY AI MARKET FOR OTHER MODALITIES, BY REGION,
2023–2030 (USD MILLION) 119
TABLE 47 RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 121
TABLE 48 RADIOLOGY AI MARKET FOR ONCOLOGY, BY REGION, 2023–2030 (USD MILLION) 122
TABLE 49 RADIOLOGY AI MARKET FOR CARDIOLOGY, BY REGION,
2023–2030 (USD MILLION) 123
TABLE 50 RADIOLOGY AI MARKET FOR NEUROLOGY, BY REGION, 2023–2030 (USD MILLION) 124
TABLE 51 RADIOLOGY AI MARKET FOR PULMONOLOGY/RESPIRATORY DISEASES,
BY REGION, 2023–2030 (USD MILLION) 125
TABLE 52 RADIOLOGY AI MARKET FOR ORTHOPEDICS, BY REGION,
2023–2030 (USD MILLION) 126
TABLE 53 RADIOLOGY AI MARKET FOR WOMEN’S HEALTH, BY REGION,
2023–2030 (USD MILLION) 126
TABLE 54 RADIOLOGY AI MARKET FOR OTHER INDICATIONS, BY REGION,
2023–2030 (USD MILLION) 127
TABLE 55 RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 129
TABLE 56 RADIOLOGY AI MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 130
TABLE 57 RADIOLOGY AI MARKET FOR DIAGNOSTIC IMAGING CENTERS,
BY REGION, 2023–2030 (USD MILLION) 131
TABLE 58 RADIOLOGY AI MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 132
TABLE 59 RADIOLOGY AI MARKET, BY REGION, 2023–2030 (USD MILLION) 134
TABLE 60 NORTH AMERICA: RADIOLOGY AI MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 137
TABLE 61 NORTH AMERICA: RADIOLOGY AI MARKET, BY OFFERING,
2023–2030 (USD MILLION) 137
TABLE 62 NORTH AMERICA: RADIOLOGY AI MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 137
TABLE 63 NORTH AMERICA: RADIOLOGY AI MARKET, BY MODALITY,
2023–2030 (USD MILLION) 138
TABLE 64 NORTH AMERICA: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 138
TABLE 65 NORTH AMERICA: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 139
TABLE 66 US: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 140
TABLE 67 US: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 140
TABLE 68 US: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 141
TABLE 69 US: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 141
TABLE 70 US: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 142
TABLE 71 CANADA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 143
TABLE 72 CANADA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 143
TABLE 73 CANADA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 144
TABLE 74 CANADA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 144
TABLE 75 CANADA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 145
TABLE 76 EUROPE: RADIOLOGY AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 77 EUROPE: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 146
TABLE 78 EUROPE: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 147
TABLE 79 EUROPE: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 147
TABLE 80 EUROPE: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 148
TABLE 81 EUROPE: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 148
TABLE 82 GERMANY: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 149
TABLE 83 GERMANY: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 149
TABLE 84 GERMANY: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 150
TABLE 85 GERMANY: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 150
TABLE 86 GERMANY: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 151
TABLE 87 FRANCE: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 152
TABLE 88 FRANCE: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 152
TABLE 89 FRANCE: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 153
TABLE 90 FRANCE: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 153
TABLE 91 FRANCE: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 154
TABLE 92 UK: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 155
TABLE 93 UK: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 155
TABLE 94 UK: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 156
TABLE 95 UK: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 156
TABLE 96 UK: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 157
TABLE 97 ITALY: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 158
TABLE 98 ITALY: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 158
TABLE 99 ITALY: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 159
TABLE 100 ITALY: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 159
TABLE 101 ITALY: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 160
TABLE 102 SPAIN: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 161
TABLE 103 SPAIN: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 161
TABLE 104 SPAIN: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 162
TABLE 105 SPAIN: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 162
TABLE 106 SPAIN: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 163
TABLE 107 REST OF EUROPE: RADIOLOGY AI MARKET, BY OFFERING,
2023–2030 (USD MILLION) 163
TABLE 108 REST OF EUROPE: RADIOLOGY AI MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 164
TABLE 109 REST OF EUROPE: RADIOLOGY AI MARKET, BY MODALITY,
2023–2030 (USD MILLION) 164
TABLE 110 REST OF EUROPE: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 165
TABLE 111 REST OF EUROPE: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 165
TABLE 112 ASIA PACIFIC: RADIOLOGY AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 113 ASIA PACIFIC: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 167
TABLE 114 ASIA PACIFIC: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 168
TABLE 115 ASIA PACIFIC: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 168
TABLE 116 ASIA PACIFIC: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 169
TABLE 117 ASIA PACIFIC: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 169
TABLE 118 JAPAN: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 170
TABLE 119 JAPAN: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 171
TABLE 120 JAPAN: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 171
TABLE 121 JAPAN: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 172
TABLE 122 JAPAN: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 172
TABLE 123 CHINA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 173
TABLE 124 CHINA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 174
TABLE 125 CHINA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 174
TABLE 126 CHINA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 175
TABLE 127 CHINA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 175
TABLE 128 INDIA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 176
TABLE 129 INDIA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 177
TABLE 130 INDIA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 177
TABLE 131 INDIA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 178
TABLE 132 INDIA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 178
TABLE 133 SOUTH KOREA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 179
TABLE 134 SOUTH KOREA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 180
TABLE 135 SOUTH KOREA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 180
TABLE 136 SOUTH KOREA: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 181
TABLE 137 SOUTH KOREA: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 181
TABLE 138 AUSTRALIA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 182
TABLE 139 AUSTRALIA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 183
TABLE 140 AUSTRALIA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 183
TABLE 141 AUSTRALIA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 184
TABLE 142 AUSTRALIA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 184
TABLE 143 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY OFFERING,
2023–2030 (USD MILLION) 185
TABLE 144 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 185
TABLE 145 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY MODALITY,
2023–2030 (USD MILLION) 186
TABLE 146 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 186
TABLE 147 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 187
TABLE 148 LATIN AMERICA: RADIOLOGY AI MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 188
TABLE 149 LATIN AMERICA: RADIOLOGY AI MARKET, BY OFFERING,
2023–2030 (USD MILLION) 188
TABLE 150 LATIN AMERICA: RADIOLOGY AI MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 189
TABLE 151 LATIN AMERICA: RADIOLOGY AI MARKET, BY MODALITY,
2023–2030 (USD MILLION) 189
TABLE 152 LATIN AMERICA: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 190
TABLE 153 LATIN AMERICA: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 190
TABLE 154 BRAZIL: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 191
TABLE 155 BRAZIL: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 192
TABLE 156 BRAZIL: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 192
TABLE 157 BRAZIL: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 193
TABLE 158 BRAZIL: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 193
TABLE 159 MEXICO: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 194
TABLE 160 MEXICO: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 194
TABLE 161 MEXICO: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 195
TABLE 162 MEXICO: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 195
TABLE 163 MEXICO: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 196
TABLE 164 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY OFFERING,
2023–2030 (USD MILLION) 197
TABLE 165 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 197
TABLE 166 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY MODALITY,
2023–2030 (USD MILLION) 198
TABLE 167 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 198
TABLE 168 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 199
TABLE 169 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 200
TABLE 170 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY OFFERING,
2023–2030 (USD MILLION) 200
TABLE 171 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 201
TABLE 172 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY MODALITY,
2023–2030 (USD MILLION) 201
TABLE 173 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 202
TABLE 174 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 202
TABLE 175 GCC COUNTRIES: RADIOLOGY AI MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 203
TABLE 176 GCC COUNTRIES: RADIOLOGY AI MARKET, BY OFFERING,
2023–2030 (USD MILLION) 203
TABLE 177 GCC COUNTRIES: RADIOLOGY AI MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 204
TABLE 178 GCC COUNTRIES: RADIOLOGY AI MARKET, BY MODALITY,
2023–2030 (USD MILLION) 204
TABLE 179 GCC COUNTRIES: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 205
TABLE 180 GCC COUNTRIES: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 205
TABLE 181 SAUDI ARABIA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 206
TABLE 182 SAUDI ARABIA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 207
TABLE 183 SAUDI ARABIA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 207
TABLE 184 SAUDI ARABIA: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 208
TABLE 185 SAUDI ARABIA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 208
TABLE 186 UAE: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 209
TABLE 187 UAE: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 210
TABLE 188 UAE: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 210
TABLE 189 UAE: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 211
TABLE 190 UAE: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 211
TABLE 191 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY OFFERING,
2023–2030 (USD MILLION) 212
TABLE 192 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 213
TABLE 193 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY MODALITY,
2023–2030 (USD MILLION) 213
TABLE 194 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 214
TABLE 195 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 214
TABLE 196 SOUTH AFRICA: RADIOLOGY AI MARKET, BY OFFERING,
2023–2030 (USD MILLION) 215
TABLE 197 SOUTH AFRICA: RADIOLOGY AI MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 215
TABLE 198 SOUTH AFRICA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 216
TABLE 199 SOUTH AFRICA: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 216
TABLE 200 SOUTH AFRICA: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 217
TABLE 201 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY OFFERING,
2023–2030 (USD MILLION) 218
TABLE 202 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 218
TABLE 203 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY MODALITY,
2023–2030 (USD MILLION) 219
TABLE 204 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY INDICATION,
2023–2030 (USD MILLION) 219
TABLE 205 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY END USER,
2023–2030 (USD MILLION) 220
TABLE 206 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOLOGY AI MARKET, JANUARY 2022–NOVEMBER 2025 221
TABLE 207 RADIOLOGY AI MARKET: DEGREE OF COMPETITION 226
TABLE 208 RADIOLOGY AI MARKET: REGION FOOTPRINT 231
TABLE 209 RADIOLOGY AI MARKET: OFFERING FOOTPRINT 231
TABLE 210 RADIOLOGY AI MARKET: FUNCTION FOOTPRINT 232
TABLE 211 RADIOLOGY AI MARKET: MODALITY FOOTPRINT 233
TABLE 212 RADIOLOGY AI MARKET: END-USER FOOTPRINT 234
TABLE 213 RADIOLOGY AI MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 237
TABLE 214 RADIOLOGY AI MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS AND SMES, BY REGION 238
TABLE 215 RADIOLOGY AI MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS AND SMES, BY MODALITY 239
TABLE 216 RADIOLOGY AI MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS AND SMES, BY END USER 240
TABLE 217 RADIOLOGY AI MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2022–NOVEMBER 2025 241
TABLE 218 RADIOLOGY AI MARKET: DEALS, JANUARY 2022–NOVEMBER 2025 242
TABLE 219 RADIOLOGY AI MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–NOVEMBER 2025 243
TABLE 220 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 244
TABLE 221 SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED 245
TABLE 222 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES,
JANUARY 2022–NOVEMBER 2025 247
TABLE 223 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–NOVEMBER 2025 247
TABLE 224 SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS,
JANUARY 2022–NOVEMBER 2025 249
TABLE 225 MICROSOFT: COMPANY OVERVIEW 251
TABLE 226 MICROSOFT: SOLUTIONS OFFERED 252
TABLE 227 MICROSOFT: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 253
TABLE 228 MICROSOFT: DEALS, JANUARY 2022–NOVEMBER 2025 254
TABLE 229 MICROSOFT: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 255
TABLE 230 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 257
TABLE 231 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED 259
TABLE 232 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–NOVEMBER 2025 261
TABLE 233 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–NOVEMBER 2025 262
TABLE 234 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS,
JANUARY 2022–NOVEMBER 2025 263
TABLE 235 GE HEALTHCARE: COMPANY OVERVIEW 265
TABLE 236 GE HEALTHCARE: SOLUTIONS OFFERED 266
TABLE 237 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–NOVEMBER 2025 267
TABLE 238 GE HEALTHCARE: DEALS, JANUARY 2022–NOVEMBER 2025 268
TABLE 239 GE HEALTHCARE: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 270
TABLE 240 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 270
TABLE 241 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 272
TABLE 242 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED 273
TABLE 243 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–NOVEMBER 2025 276
TABLE 244 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2022–NOVEMBER 2025 276
TABLE 245 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2022–NOVEMBER 2025 277
TABLE 246 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): COMPANY OVERVIEW 279
TABLE 247 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): SOLUTIONS OFFERED 280
TABLE 248 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 281
TABLE 249 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): DEALS,
JANUARY 2022–NOVEMBER 2025 282
TABLE 250 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.):
OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 282
TABLE 251 MERATIVE: COMPANY OVERVIEW 283
TABLE 252 MERATIVE: SOLUTIONS OFFERED 284
TABLE 253 MERATIVE: DEALS, JANUARY 2022–NOVEMBER 2025 285
TABLE 254 MERATIVE: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 286
TABLE 255 MERATIVE: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 287
TABLE 256 RADNET, INC. (DEEPHEALTH): COMPANY OVERVIEW 288
TABLE 257 RADNET, INC. (DEEPHEALTH): SOLUTIONS OFFERED 289
TABLE 258 RADNET, INC. (DEEPHEALTH): PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 291
TABLE 259 RADNET, INC. (DEEPHEALTH): DEALS, JANUARY 2022–NOVEMBER 2025 292
TABLE 260 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW 293
TABLE 261 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: SOLUTIONS OFFERED 294
TABLE 262 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 295
TABLE 263 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: DEALS,
JANUARY 2022–NOVEMBER 2025 296
TABLE 264 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.:
OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 296
TABLE 265 HOLOGIC, INC.: COMPANY OVERVIEW 298
TABLE 266 HOLOGIC, INC.: SOLUTIONS OFFERED 299
TABLE 267 HOLOGIC, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–NOVEMBER 2025 300
TABLE 268 HOLOGIC, INC. : DEALS, JANUARY 2022–NOVEMBER 2025 301
TABLE 269 HOLOGIC, INC.: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 301
TABLE 270 ENLITIC, INC.: COMPANY OVERVIEW 303
TABLE 271 ENLITIC, INC.: SOLUTIONS OFFERED 304
TABLE 272 ENLITIC, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–NOVEMBER 2025 305
TABLE 273 ENLITIC, INC.: DEALS, JANUARY 2022–NOVEMBER 2025 305
TABLE 274 ENLITIC, INC.: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 306
TABLE 275 AIDOC: COMPANY OVERVIEW 307
TABLE 276 VIZ.AI, INC.: COMPANY OVERVIEW 308
TABLE 277 NANOX: COMPANY OVERVIEW 309
TABLE 278 QURE.AI: COMPANY OVERVIEW 310
TABLE 279 ESAOTE S.P.A.: COMPANY OVERVIEW 311
TABLE 280 BUTTERFLY NETWORK INC.: COMPANY OVERVIEW 312
TABLE 281 HEARTFLOW, INC.: COMPANY OVERVIEW 313
TABLE 282 SUBTLE MEDICAL, INC.: COMPANY OVERVIEW 314
TABLE 283 HARISSON.AI: COMPANY OVERVIEW 315
TABLE 284 ECHONOUS INC.: COMPANY OVERVIEW 316
TABLE 285 QUIBIM: COMPANY OVERVIEW 317
TABLE 286 IMAGEN: COMPANY OVERVIEW 318
TABLE 287 EXO IMAGING, INC.: COMPANY OVERVIEW 319
TABLE 288 RAD AI: COMPANY OVERVIEW 320
TABLE 289 FACTOR ANALYSIS 331
TABLE 290 RISK ASSESSMENT: RADIOLOGY AI MARKET 336

LIST OF FIGURES

FIGURE 1 RADIOLOGY AI MARKET SEGMENTATION & REGIONAL SCOPE 28
FIGURE 2 MARKET SCENARIO 32
FIGURE 3 GLOBAL RADIOLOGY AI MARKET, 2023–2030 33
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOLOGY AI MARKET,
2020–2025 33
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF RADIOLOGY AI MARKET 34
FIGURE 6 HIGH-GROWTH SEGMENTS IN RADIOLOGY AI MARKET, 2025–2030 35
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN RADIOLOGY AI MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 36
FIGURE 8 RISING IMAGING VOLUMES TO DRIVE GROWTH IN RADIOLOGY AI MARKET 37
FIGURE 9 SOFTWARE/SAAS SEGMENT IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 38
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 38
FIGURE 11 RADIOLOGY AI MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 39
FIGURE 12 FDA-APPROVED AI-ENABLED RADIOLOGY (2019–MAY 2025) 43
FIGURE 13 PROVEN ACCURACY RATES OF AI IN DIAGNOSTIC IMAGING 44
FIGURE 14 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024 53
FIGURE 15 US: MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR, 2009–2024 54
FIGURE 16 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 54
FIGURE 17 RADIOLOGY AI MARKET: PORTER’S FIVE FORCES ANALYSIS 59
FIGURE 18 RADIOLOGY AI MARKET: SUPPLY CHAIN ANALYSIS (2024) 62
FIGURE 19 RADIOLOGY AI MARKET: ECOSYSTEM ANALYSIS 64
FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68
FIGURE 22 PATENT PUBLICATION TRENDS IN RADIOLOGY AI MARKET, 2015–2025 79
FIGURE 23 JURISDICTION & TOP APPLICANT ANALYSIS FOR RADIOLOGY AI MARKET 79
FIGURE 24 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR RADIOLOGY AI MARKET (JANUARY 2015 TO NOVEMBER 2025) 80
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 95
FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS 96
FIGURE 27 NORTH AMERICA: RADIOLOGY AI MARKET SNAPSHOT 136
FIGURE 28 ASIA PACIFIC: RADIOLOGY AI MARKET SNAPSHOT 166
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN RADIOLOGY AI MARKET,
2020–2024 (USD MILLION) 224
FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN RADIOLOGY AI MARKET (2024) 225
FIGURE 31 RADIOLOGY AI MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 227
FIGURE 32 RADIOLOGY AI MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 229
FIGURE 33 RADIOLOGY AI MARKET: COMPANY FOOTPRINT 230
FIGURE 34 RADIOLOGY AI MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 236
FIGURE 35 EV/EBITDA OF KEY VENDORS 240
FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 241
FIGURE 37 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 245
FIGURE 38 MICROSOFT: COMPANY SNAPSHOT 252
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 258
FIGURE 40 GE HEALTHCARE: COMPANY SNAPSHOT 266
FIGURE 41 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 273
FIGURE 42 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): COMPANY SNAPSHOT 280
FIGURE 43 RADNET, INC. (DEEPHEALTH): COMPANY SNAPSHOT 289
FIGURE 44 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT 293
FIGURE 45 HOLOGIC, INC.: COMPANY SNAPSHOT 299
FIGURE 46 ENLITIC, INC.: COMPANY SNAPSHOT 304
FIGURE 47 RESEARCH DESIGN 321
FIGURE 48 PRIMARY SOURCES 323
FIGURE 49 INSIGHTS FROM INDUSTRY EXPERTS 325
FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 325
FIGURE 51 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 326
FIGURE 52 SUPPLY-SIDE MARKET ESTIMATION 328
FIGURE 53 RADIOLOGY AI MARKET: REVENUE ESTIMATION APPROACH 328
FIGURE 54 BOTTOM-UP APPROACH: END-USER SPENDING ON RADIOLOGY AI 330
FIGURE 55 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 332
FIGURE 56 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 333
FIGURE 57 TOP-DOWN APPROACH 333
FIGURE 58 DATA TRIANGULATION METHODOLOGY 334

---

---